The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression

Biochemistry and Cell Biology

Volumn 91, Issue 6, 2013, Pages 369-377

  Young, Leah C ^a   Hendzel, Michael J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

cancer; demethylase; H3K9me3; JMJD2 KDM4; Jumonji

Indexed keywords

ANIMALS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN ASSEMBLY AND DISASSEMBLY; DROSOPHILA MELANOGASTER; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEMETHYLASES; HISTONES; HUMANS; ISOENZYMES; METHYLATION; MICE; MICE, TRANSGENIC; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84880543767     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2012-0054     Document Type: Review

References (89)

1. Aagaard L. Schmid M. Warburton P. Jenuwein T. 2000. Mitotic phosphorylation of SUV39H1, a novel component of active centromeres, coincides with transient accumulation at mammalian centromeres. J. Cell Sci. 113 (5): 817-829. 10671371.
2. Albert M. Helin K. 2010. Histone methyltransferases in cancer. Semin. Cell Dev. Biol. 21 (2): 209-220. 10.1016/j.semcdb.2009.10.007. 19892027.
3. Bartova E. Stixova L. Galiova G. Harnicarova H.A. Legartova S. Kozubek S. 2011. Mutant genetic background affects the functional rearrangement and kinetic properties of JMJD2b histone demethylase. J. Mol. Biol. 405 (3): 679-695. 10.1016/j.jmb.2010.11.001. 21073875.
4. Beyer S. Kristensen M.M. Jensen K.S. Johansen J.V. Staller P. 2008. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 283 (52): 36542-36552. 10.1074/jbc.M804578200. 18984585.
5. Bjorkman M. Ostling P. Harma V. Virtanen J. Mpindi J.P. Rantala J. et al. 2011. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene. doi: 10.1038/onc.2011.512. PMID: 22120715.
6. Black J.C. Allen A. Van R.C. Forbes E. Longworth M. Tschop K. et al. 2010. Conserved antagonism between JMJD2A/KDM4A and HP1gamma during cell cycle progression. Mol. Cell, 40 (5): 736-748. 10.1016/j.molcel.2010.11.008. 21145482.
7. Bock I. Kudithipudi S. Tamas R. Kungulovski G. Dhayalan A. Jeltsch A. 2011. Application of Celluspots peptide arrays for the analysis of the binding specificity of epigenetic reading domains to modified histone tails. BMC Biochem. 12 (48): 1-12. 10.1186/1471-2091-12-1. 21205312.
8. Chen Z. Zang J. Whetstine J. Hong X. Davrazou F. Kutateladze T.G. et al. 2006. Structural insights into histone demethylation by JMJD2 family members. Cell, 125 (4): 691-702. 10.1016/j.cell.2006.04.024. 16677698.
9. Chen Z. Zang J. Kappler J. Hong X. Crawford F. Wang Q. et al. 2007. Structural basis of the recognition of a methylated histone tail by JMJD2A. Proc. Natl. Acad. Sci. U.S.A. 104 (26): 10818-10823. 10.1073/pnas.0704525104. 17567753.
10. Cloos P.A. Christensen J. Agger K. Maiolica A. Rappsilber J. Antal T. et al. 2006. The putative oncogene GASC1 demethylates tri-and dimethylated lysine 9 on histone H3. Nature, 442 (7100): 307-311. 10.1038/nature04837. 16732293.
11. Couture J.F. Collazo E. Ortiz-Tello P.A. Brunzelle J.S. Trievel R.C. 2007. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat. Struct. Mol. Biol. 14 (8): 689-695. 10.1038/nsmb1273. 17589523.
12. Dialynas G.K. Vitalini M.W. Wallrath L.L. 2008. Linking Heterochromatin Protein 1 (HP1) to cancer progression. Mutat. Res. 647 (1-2): 13-20. 10.1016/j.mrfmmm.2008.09.007. 18926834.
13. Dontu G. Abdallah W.M. Foley J.M. Jackson K.W. Clarke M.F. Kawamura M.J. Wicha M.S. 2003. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17 (10): 1253-1270. 10.1101/gad.1061803. 12756227.
14. Dorn E.S. Cook J.G. 2011. Nucleosomes in the neighborhood: new roles for chromatin modifications in replication origin control. Epigenetics, 6 (5): 552-559. 10.4161/epi.6.5.15082. 21364325.
15. Duns G. van den Berg E. van Duivenbode I Osinga J. Hollema H. Hofstra R.M.W. Kok K. 2010. Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma. Cancer Res. 70 (11): 4287-4291. 10.1158/0008-5472.CAN-10-0120. 20501857.
16. Eissenberg J.C. 2012. Structural biology of the chromodomain: form and function. Gene, 496 (2): 69-78. 10.1016/j.gene.2012.01.003. 22285924.
17. Ellinger J. Kahl P. Mertens C. Rogenhofer S. Hauser S. Hartmann W. et al. 2010 a. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma. Int. J. Cancer, 127 (10): 2360-2366. 10.1002/ijc.25250. 20162570.
18. Ellinger J. Kahl P. von der Gathen J. Rogenhofer S. Heukamp L.C. Gutgemann I. et al. 2010 b. Global levels of histone modifications predict prostate cancer recurrence. Prostate, 70 (1): 61-69. 10.1002/pros.21038. 19739128.
19. Elsheikh S.E. Green A.R. Rakha E.A. Powe D.G. Ahmed R.A. Collins H.M. et al. 2009. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69 (9): 3802-3809. 10.1158/0008-5472.CAN-08-3907. 19366799.
20. Fodor B.D. Kubicek S. Yonezawa M. O'Sullivan R.J. Sengupta R. Perez-Burgos L. et al. 2006. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 20 (12): 1557-1562. 10.1101/gad.388206. 16738407.
21. Gray S.G. Iglesias A.H. Lizcano F. Villanueva R. Camelo S. Jingu H. et al. 2005. Functional characterization of JMJD2A, a histone deacetylase-and retinoblastoma-binding protein. J. Biol. Chem. 280 (31): 28507-28518. 10.1074/jbc.M413687200. 15927959.
22. Heightman T.D. 2011. Chemical biology of lysine demethylases. Curr. Chem. Genomics, 5 (Suppl. 1): 62-71. 10.2174/1875397301005010062. PMID: 21966346.
23. Heit R. Rattner J.B. Chan G.K. Hendzel M.J. 2009. G2 histone methylation is required for the proper segregation of chromosomes. J. Cell Sci. 122 (16): 2957-2968. 10.1242/jcs.045351. 19638412.
24. Hillringhaus L. Yue W.W. Rose N.R. Ng S.S. Gileadi C. Loenarz C. et al. 2011. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family. J. Biol. Chem. 286 (48): 41616-41625. 10.1074/jbc.M111.283689. 21914792.
25. Huang Y. Fang J. Bedford M.T. Zhang Y. Xu R.M. 2006. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science, 312 (5774): 748-751. 10.1126/science.1125162. 16601153.
26. Huang J. Sengupta R. Espejo A.B. Lee M.G. Dorsey J.A. Richter M. et al. 2007. p53 is regulated by the lysine demethylase LSD1. Nature, 449 (7158): 105-108. 10.1038/nature06092. 17805299.
27. Ishimura A. Terashima M. Kimura H. Akagi K. Suzuki Y. Sugano S. Suzuki T. 2009. Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene. Biochem. Biophys. Res. Commun. 389 (2): 366-371. 10.1016/j.bbrc.2009.08.155. 19732750.
28. Italiano A. Attias R. Aurias A. Perot G. Burel-Vandenbos F. Otto J. et al. 2006. Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23-p24 amplification including JAK2 and JMJD2C. Cancer Genet. Cytogenet. 167 (2): 122-130. 10.1016/j. cancergencyto.2006.01.004. 16737911.
29. Iwamori N. Zhao M. Meistrich M.L. Matzuk M.M. 2011. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol. Reprod. 84 (6): 1225-1234. 10.1095/biolreprod.110.088955. 21293030.
30. Katoh M. Katoh M. 2004. Identification and characterization of JMJD2 family genes in silico. Int. J. Oncol. 24 (6): 1623-1628. 15138608.
31. Kawazu M. Saso K. Tong K.I. McQuire T. Goto K. Son D.O. et al. 2011. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One, 6 (3): e17830. 10.1371/journal.pone.0017830. 21445275.
32. Kim J. Daniel J. Espejo A. Lake A. Krishna M. Xia L. et al. 2006. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 7 (4): 397-403. 10.1038/sj.embor.7400625. 16415788.
33. Kim T.D. Shin S. Berry W.L. Oh S. Janknecht R. 2011. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. J. Cell Biochem. 113 (4): 1368-1376. 10.1002/jcb.24009. 22134899.
34. Kim T.D. Oh S. Shin S. Janknecht R. 2012. Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D. PLoS One, 7 (4): e34618. 10.1371/journal.pone.0034618. 22514644.
35. King O.N. Li X.S. Sakurai M. Kawamura A. Rose N.R. Ng S.S. et al. 2010. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors. PLoS One, 5 (11): e15535. 10.1371/journal.pone.0015535. 21124847.
36. Klose R.J. Yamane K. Bae Y. Zhang D. Erdjument-Bromage H. Tempst P. et al. 2006. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature, 442 (7100): 312-316. 10.1038/nature04853. 16732292.
37. Knudsen K.E. Penning T.M. 2010. Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol. Metab 21 (5): 315-324. 10.1016/j.tem.2010.01.002. 20138542.
38. Krieg A.J. Rankin E.B. Chan D. Razorenova O. Fernandez S. Giaccia A.J. 2010. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol. Cell. Biol. 30 (1): 344-353. 10.1128/MCB.00444-09. 19858293.
39. Krissinel, E., and Henrick, K. 2012. Protein structure comparison service Fold at European Bioinformatics Institute. Available from www.ebi.ac.uk/msd- srv/ssm.
40. Lee J. Thompson J.R. Botuyan M.V. Mer G. 2008. Distinct binding modes specify the recognition of methylated histones H3K4 and H4K20 by JMJD2A-tudor. Nat. Struct. Mol. Biol. 15 (1): 109-111. 10.1038/nsmb1326. 18084306.
41. Li B.X. Zhang M.C. Luo C.L. Yang P. Li H. Xu H.M. et al. 2011 a. Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro. J. Exp. Clin. Cancer Res. 30: 90. 10.1186/1756-9966-30-90. 21962223.
42. Li W. Zhao L. Zang W. Liu Z. Chen L. Liu T. et al. 2011 b. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer. Biochem. Biophys. Res. Commun. 416 (3-4): 372-378. 10.1016/j.bbrc.2011.11.045. 22133676.
43. Liu G. Bollig-Fischer A. Kreike B. van de Vijver M.J. Abrams J. Ethier S.P. Yang Z.Q. 2009. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene, 28 (50): 4491-4500. 10.1038/onc.2009.297. 19784073.
44. Liu Y. Zheng P. Liu Y. Ji T. Liu X. Yao S. et al. 2012. An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer. Gut. In press. doi: 10.1136/gutjnl-2011-301059. PMID: 22345654.
45. Lloret-Llinares M. Carré C. Vaquero A. de Olano N. Azorin F. 2008. Characterization of Drosophila melanogaster JmjC+N histone demethylases. Nucleic Acids Res. 36 (9): 2852-2863. 10.1093/nar/gkn098. 18375980.
46. Loh Y.H. Zhang W. Chen X. George J. Ng H.H. 2007. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21 (20): 2545-2557. 10.1101/gad.1588207. 17938240.
47. Lorbeck M.T. Singh N. Zervos A. Dhatta M. Lapchenko M. Yang C. Elefant F. 2010. The histone demethylase Dmel\Kdm4A controls genes required for life span and male-specific sex determination in Drosophila. Gene, 450 (1-2): 8-17. 10.1016/j.gene.2009.09.007. 19786080.
48. Lu C. Ward P.S. Kapoor G.S. Rohle D. Turcan S. Abdel-Wahab O. et al. 2012. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature, 483 (7390): 474-478. 10.1038/nature10860. 22343901.
49. Mallette F.A. Mattiroli F. Cui G. Young L.C. Hendzel M.J. Mer G. et al. 2012. RNF8-and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J. 31 (8): 1865-1878. 10.1038/emboj.2012. 47. 22373579.
50. Manuyakorn A. Paulus R. Farrell J. Dawson N.A. Tze S. Cheung-Lau G. et al. 2010. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J. Clin. Oncol. 28 (8): 1358-1365. 10.1200/JCO.2009.24.5639. 20142597.
51. McGraw S. Vigneault C. Sirard M.A. 2007. Temporal expression of factors involved in chromatin remodeling and in gene regulation during early bovine in vitro embryo development. Reproduction, 133 (3): 597-608. 10.1530/REP-06-0251. 17379654.
52. McManus K.J. Biron V.L. Heit R. Underhill D.A. Hendzel M.J. 2006. Dynamic changes in histone H3 lysine 9 methylations: identification of a mitosis-specific function for dynamic methylation in chromosome congression and segregation. J. Biol. Chem. 281 (13): 8888-8897. 10.1074/jbc.M505323200. 16373353.
53. Musselman C.A. Kutateladze T.G. 2009. PHD fingers: epigenetic effectors and potential drug targets. Mol. Interv. 9 (6): 314-323. 10.1124/mi.9.6.7. 20048137.
54. Musselman C.A. Kutateladze T.G. 2011. Handpicking epigenetic marks with PHD fingers. Nucleic Acids Res. 39 (21): 9061-9071. 10.1093/nar/gkr613. 21813457.
55. Nacheva E.P. Brazma D. Virgili A. Howard-Reeves J. Chanalaris A. Gancheva K. et al. 2010. Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia. BMC Genomics, 11 (41): 1-11. 10.1186/1471-2164-11-1. 20044946.
56. Ozboyaci M. Gursoy A. Erman B. Keskin O. 2011. Molecular recognition of H3/H4 histone tails by the tudor domains of JMJD2A: a comparative molecular dynamics simulations study. PLoS One, 6 (3): e14765. 10.1371/journal.pone. 0014765. 21464980.
57. Palomera-Sanchez Z. Bucio-Mendez A. Valadez-Graham V. Reynaud E. Zurita M. 2010. Drosophila p53 is required to increase the levels of the dKDM4B demethylase after UV-induced DNA damage to demethylate histone H3 lysine 9. J. Biol. Chem. 285 (41): 31370-31379. 10.1074/jbc.M110.128462. 20675387.
58. Peng J.C. Karpen G.H. 2009. Heterochromatic genome stability requires regulators of histone H3 K9 methylation. PLoS. Genet. 5 (3): e1000435. 10.1371/journal.pgen.1000435. 19325889.
59. Peters A.H. O'Carroll D. Scherthan H. Mechtler K. Sauer S. Schofer C. et al. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell, 107 (3): 323-337. 10.1016/S0092-8674(01)00542-6. 11701123.
60. Peters A.H. Kubicek S. Mechtler K. O'Sullivan R.J. Derijck A.A. Perez-Burgos L. et al. 2003. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol. Cell, 12 (6): 1577-1589. 10.1016/S1097-2765(03)00477-5. 14690609.
61. Pollard P.J. Loenarz C. Mole D.R. McDonough M.A. Gleadle J.M. Schofield C.J. Ratcliffe P.J. 2008. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem J. 416 (3): 387-394. 10.1042/BJ20081238. 18713068.
62. Ponnaluri V.K. Vavilala D.T. Putty S. Gutheil W.G. Mukherji M. 2009. Identification of non-histone substrates for JMJD2A-C histone demethylases. Biochem. Biophys. Res. Commun. 390 (2): 280-284. 10.1016/j.bbrc.2009.09.107. 19799855.
63. Pryor J.G. Brown-Kipphut B.A. Iqbal A. Scott G.A. 2011. Microarray Comparative Genomic Hybridization Detection of Copy Number Changes in Desmoplastic Melanoma and Malignant Peripheral Nerve Sheath Tumor. Am. J. Dermatopathol. 33 (8): 750-758. 10.1097/DAD.0b013e31820978cf. 21885941.
64. Rui L. Emre N.C. Kruhlak M.J. Chung H.J. Steidl C. Slack G. et al. 2010. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell, 18 (6): 590-605. 10.1016/j.ccr.2010.11.013. 21156283.
65. Schwaiger M. Kohler H. Oakeley E.J. Stadler M.B. Schubeler D. 2010. Heterochromatin protein 1 (HP1) modulates replication timing of the Drosophila genome. Genome Res. 20 (6): 771-780. 10.1101/gr.101790.109. 20435908.
66. Shi Y. Lan F. Matson C. Mulligan P. Whetstine J.R. Cole P.A. et al. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119 (7): 941-953. 10.1016/j.cell.2004.12.012. 15620353.
67. Shi L. Sun L. Li Q. Liang J. Yu W. Yi X. et al. 2011. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 108 (18): 7541-7546. 10.1073/pnas.1017374108. 21502505.
68. Shin S. Janknecht R. 2007. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem. Biophys. Res. Commun. 359 (3): 742-746. 10.1016/j.bbrc.2007.05.179. 17555712.
69. Slee R.B. Steiner C.M. Herbert B.S. Vance G.H. Hickey R.J. Schwarz T. et al. 2011. Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability. Oncogene. doi: 10.1038/onc.2011.502. PMID: 22081068.
70. Song J.S. Kim Y.S. Kim D.K. Park S.I. Jang S.J. 2012. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients. Pathol. Int. 62 (3): 182-190. 10.1111/j.1440-1827.2011.02776.x. 22360506.
71. Strobl-Mazzulla P.H. Sauka-Spengler T. Bronner-Fraser M. 2010. Histone demethylase JmjD2A regulates neural crest specification. Dev. Cell, 19 (3): 460-468. 10.1016/j.devcel.2010.08.009. 20833367.
72. Tamagawa H. Oshima T. Shiozawa M. Morinaga S. Nakamura Y. Yoshihara M. et al. 2012. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer. Oncol. Rep. 27 (3): 637-642. 22076537.
73. Tausendschon M. Dehne N. Brune B. 2011. Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity. Cytokine, 53 (2): 256-262. 10.1016/j.cyto.2010.11.002. 21131212.
74. Toyokawa G. Cho H.S. Iwai Y. Yoshimatsu M. Takawa M. Hayami S. et al. 2011. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6. Cancer Prev. Res. (Phila.), 4 (12): 2051-2061. 10.1158/1940-6207.CAPR-11-0290. 21930796.
75. Tsukada Y. Fang J. Erdjument-Bromage H. Warren M.E. Borchers C.H. Tempst P. Zhang Y. 2006. Histone demethylation by a family of JmjC domain-containing proteins. Nature, 439 (7078): 811-816. 10.1038/nature04433. 16362057.
76. Wagner E.J. Carpenter P.B. 2012. Understanding the language of Lys36 methylation at histone H3. Nat. Rev. Mol. Cell Biol. 13 (2): 115-126. 10.1038/nrm3274. 22266761.
77. Wagner R.T. Cooney A.J. 2009. OCT4: less is more. Cell Res. 19 (5): 527-528. 10.1038/cr.2009.48. 19421239.
78. Wang J. Zhang M. Zhang Y. Kou Z. Han Z. Chen D.Y. et al. 2010. The histone demethylase JMJD2C is stage-specifically expressed in preimplantation mouse embryos and is required for embryonic development. Biol. Reprod. 82 (1): 105-111. 10.1095/biolreprod.109.078055. 19696013.
79. Wei Y. Xia W. Zhang Z. Liu J. Wang H. Adsay N.V. et al. 2008. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol. Carcinog. 47 (9): 701-706. 10.1002/mc.20413. 18176935.
80. Whetstine J.R. Nottke A. Lan F. Huarte M. Smolikov S. Chen Z. et al. 2006. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell, 125 (3): 467-481. 10.1016/j.cell.2006.03.028. 16603238.
81. Wilson W.R. Hay M.P. 2011. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer, 11 (6): 393-410. 10.1038/nrc3064. 21606941.
82. Wilson B.G. Roberts C.W. 2011. SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer, 11 (7): 481-492. 10.1038/nrc3068. 21654818.
83. Wilson T.M. Ewel A. Duguid J.R. Eble J.N. Lescoe M.K. Fishel R. Kelley M.R. 1995. Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res. 55 (22): 5146-5150. 7585562.
84. Wissmann M. Yin N. Muller J.M. Greschik H. Fodor B.D. Jenuwein T. et al. 2007. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol. 9 (3): 347-353. 10.1038/ncb1546. 17277772.
85. Yang Z.Q. Imoto I. Fukuda Y. Pimkhaokham A. Shimada Y. Imamura M. et al. 2000. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 60 (17): 4735-4739. 10987278.
86. Yang J. Jubb A.M. Pike L. Buffa F.M. Turley H. Baban D. et al. 2010. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res. 70 (16): 6456-6466. 10.1158/0008-5472.CAN-10-0413. 20682797.
87. Yoon H.G. Chan D.W. Huang Z.Q. Li J. Fondell J.D. Qin J. Wong J. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22 (6): 1336-1346. 10.1093/emboj/cdg120. 12628926.
88. Yoshioka H. McCarrey J.R. Yamazaki Y. 2009. Dynamic nuclear organization of constitutive heterochromatin during fetal male germ cell development in mice. Biol. Reprod. 80 (4): 804-812. 10.1095/biolreprod.108.072603. 19129513.
89. Zhang D. Yoon H.G. Wong J. 2005. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol. Cell. Biol. 25 (15): 6404-6414. 10.1128/MCB.25.15.6404-6414.2005. 16024779.